News | September 26, 2023
Briefs: Mankind Pharma and Sequent Scientific
Mankind Pharma commences the commercial operations newly set-up plant in Udaipur
Mankind Pharma commences the commercial operations newly set-up plant in Udaipur
The acquisition is for an enterprise value of Rs. 218 crores
Brazil has the 4th largest pet market in the world with an estimated market size of BRL 1.8 billion, growing annually at 16%
Narayanan to lead SeQuent through next phase of consolidation and growth
Formulation business grew by 15 per cent in the quarter
The company has already embarked upon significant expansion in Turkey
Manish led SeQuent since 2014 and played a major role in transforming the company
A preview on Q3FY22 by Nirmal Bang Securities on select Indian pharma companies
Viyash has ten manufacturing facilities in India with a combined capacity of 2000 KL as well as one formulation facility in the US, and is now one of India’s leading mid-tier integrated API and formulation players
_256_384.jpg)
In Q2FY22, growth from Covid-driven products in the domestic branded formulation sales should dissipate on a QoQ basis as new covid cases have declined sharply. Vishal Manchanda, research analyst Nirmal Bang gives a preview of pharma companies in this report
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)